One sentence summary: Highly diverse population of E. coli, including resistant pathogenic strains of public health concern carrying plasmids with resistance genes of significance are in circulation in Canadian wildlife.
INTRODUCTION
The rapid expansion of AmpC-type beta-lactamase-and extended-spectrum beta-lactamase-producing (ESBL) bacteria has created epidemiological challenges for addressing antimicrobial resistance (AMR) (Bush and Fisher 2011; Denisuik et al. 2013; Mathers, Peirano and Pitout 2015) . Clinical efficacy of betalactams is diminishing due to an increasing prevalence of resistant bacterial pathogens, prolonging patient recovery (Denisuik et al. 2013; Mathers, Peirano and Pitout 2015) . Since their emergence, ESBLs have most often been found in Escherichia coli and Klebsiella pneumoniae (Bonnet 2004; Livermore et al. 2006; Mathers, Peirano and Pitout 2015) . The increasing trend of antimicrobial resistance dissemination and a growing detection of multidrug resistance in bacteria has become a serious threat to public health worldwide. Mobile genetic elements, such as plasmids capable of transferring antimicrobial resistance determinant elements among different bacterial populations, play an important role in the epidemiology of antimicrobial resistance (Carattoli 2013) . Plasmid incompatibility groups A/C and I1 are predominantly associated with the presence of bla CMY-2 gene in human, animal and environmental sources in Canada and other parts of North America (Mataseje et al. 2010; Folster et al. 2012; Bortolaia et al. 2014) . The worldwide spread of ESBL and AmpC resistance is now evidenced not only in hospital and healthcare systems, but also in the community, in food-producing and companion animals, in wildlife and in the environment (Folster et al. 2010; Bortolaia et al. 2014; Alcalá et al. 2016; Bonnedahl et al. 2015; Stedt et al. 2015; Jones-Dias, Manageiro and Caniça 2016) . Omnivorous synanthropic birds are at greatest risk of carriage and dissemination of antimicrobial resistant bacteria due to their proximity to human activity, foraging habits, and their ability to have large home-ranges spanning into natural habitats (Guenther, Ewers and Wieler 2011) . There is a limited amount of information regarding the genetic characterization of transmissible antimicrobial resistance genes in bacterial populations of corvid species in the United States and Europe (Jamborova et al. 2015; 2017) , however a knowledge gap still exists in Canadian wildlife thereby limiting the ability to evaluate the dispersal of important clones and plasmids carrying transmissible resistance genes in wildlife within Canada. American crows (Corvus brachyrhynchos) and common ravens (Corvus corax) are suitable target bird species to indicate the anthropogenic spread of plasmid-mediated antimicrobial resistance genes at the human-animal-environment interface.
The objectives of this study were (1) to determine the prevalence of cefotaxime resistant E. coli and Klebsiella spp and (2) to characterize plasmid-mediated AmpC beta-lactamaseand extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among corvids species roosting in winter months in Canada.
METHODS

Site Selection, sample collection and transport
During the 2012/13 winter season, a cross-sectional study with purposive sampling at corvid roosting sites was conducted.
Roost sites were selected through a number of sources including local hobby birding organizations, historical data on roosts in Canada via local media and provincial Ministries of Natural Resources contacts. Birds were not disturbed, as the site selection was conducted from a safe distance of congregating birds in the evening, and collection of faecal material was conducted immediately after the roost dispersed. Five roosting sites were identified in four provinces in Canada. American crows were identified as the corvid species in all but the British Columbia site, where samples from common raven were collected. Site coordinates, dates of collection and number of samples collected were as follows: Ontario (ON) (Waterloo, 43
• 28´N, (Jamborova et al. 2017) .
Genetic determination of AmpC and ESBL, antimicrobial susceptibility and integrons
The presence of genes encoding for AmpC (bla DHA , bla ACC-1 , bla ACC-2 , bla MOX , bla CMY and bla FOX ), ESBL or other betalactamases (bla CTX-M , bla TEM , bla OXA and bla SHV ) was determined using PCR protocols and sequencing (Table S1 , Supporting Information). Further characterization was completed only for isolates positive for AmpC and ESBL resistance genes tested. All isolates positive for AmpC or ESBL genes were tested for plasmidmediated quinolone resistance determinants using PCR and sequencing (Table S1 , Supporting Information). Antimicrobial susceptibility was conducted by the disk diffusion using the following antimicrobial agent discs (Oxoid, UK): amoxicillin-clavulanic acid (30 μg), ampicillin (10 μg), cephalothin (30 μg), ceftazidime (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), nalidixic acid (30 μg), streptomycin (10 μg), sulfamethoxazole-trimethoprim (25 μg), sulfonamide compounds (300 μg), tetracycline (30 μg) and imipenem (10 μg). CLSI guidelines were used to determine resistant (R), intermediate (I) and susceptible (S) isolates (Clinical and Laboratory Standards Institute 2014). All phenotypically resistant isolates were further screened for associated resistance genes and for class 1 and class 2 integrons by PCR (Table  S1 , Supporting Information). The structure of a variable region of the integrons that contained gene cassettes encoding resistance to antimicrobials was determined by restriction fragment length polymorphism (RFLP; Jamborova et al. 2017) or by sequencing of the PCR amplicons.
Molecular characterization of E. coli and K. pneumoniae isolates
Genomic relatedness of E. coli isolates was determined by XbaI pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Microbial genomic macrorestriction patterns were analyzed by BioNumerics (version 6.6) software (Applied Maths, Ghent, Belgium). UPGMA cluster analysis was used to generate dendrograms describing the relationships among the PFGE profiles as previously described (Jamborova et al. 2015) . The minimum level of similarity between the PFGE patterns was defined to be 100%, and therefore isolates were uniquely assigned to one cluster.
Multilocus sequence typing (MLST) was performed to analyze the epidemiological relatedness of E. coli (Wirth et al. 2006) and Klebsiella pneumoniae (Diancourt et al. 2005) . E. coli sequences were typed utilizing the MLST database at the University of Warwick for E. coli (MLST Database at UoW and software) and the Institut Pasteur MLST database for K. pneumoniae (Institut Pasteur MLST databases and software).
Phylogenetic type affiliation was determined by multiplex PCR assay (Clermont, Bonacorsi and Bingen 2000) . PCR-based methods were used for E. coli ST131 subtyping, including the H30, H30Rx subclones and O25 typing (Price et al. 2013; Johnson et al. 2014) .
Transferability and typing of AmpC and ESBL plasmids
Conjugation and transformation assays were performed to determine transferability of ESBL and AmpC plasmids. Plasmids extracted from donor strains using alkaline lysis were subsequently used for heat-shock transformation of plasmidfree E. coli recipient cells DH5α or TOP10. Transformants were selected on LB agar (Difco, France) supplemented with 2 mg/L cefotaxime. The filter-mating method was used to assess conjugative transfer of ESBL and AmpC plasmids to plasmidfree rifampicin-and sodium azide-resistant E. coli MT102 and Salmonella Typhimurium SL5325 or Salmonella Enteritidis Fa8065 recipients as previously described (Dobiasova and Dolejska 2016) . In order to evaluate the ability of plasmid spread to other species including bacterial pathogens, conjugation transfer was performed also with Salmonella Typhimurium SL5325 or in case of ciprofloxacin resistant strains with Salmonella Enteritidis Fa8065 recipients. Successful transfer of the resistance plasmid was tested by PCR targeting ESBL and AmpC genes.
The numbers and sizes of transferred plasmids to recipient cells were estimated by S1-PFGE. Only transformants or transconjugants carrying one single plasmid with an ESBL or AmpC gene were included in the further analysis. Plasmids were classified into incompatibility (Inc) groups by PCR-based replicon typing (PBRT) (Carattoli et al. 2005; Lv et al. 2013) and tested for the presence of additional antimicrobial resistance genes and the gene encoding colicin Ib using PCR assays (Table S1 , Supporting Information). IncI1, IncN and IncA/C plasmids were categorized by plasmid MLST (García-Fernández et al. 2008; Carattoli 2011; Hancock et al. 2016) . The presence of small plasmids in transconjugants and transformants was confirmed using standard electrophoresis of total plasmid DNA isolated by Presto R Midi Plasmid Kit (Geneaid Biotech Ltd., Taiwan).
Statistical analysis
Univariable statistical analysis using OpenEpi version 3.01 (OpenEpi Menu) was conducted for geographical locations with the dependent variable of AmpC presence, using Nova Scotia collection site as the referent group. Odds ratio (OR) and confidence intervals (CI) were calculated with Fisher's exact tests, using P < 0.05 as the significance cut-off.
RESULTS
Phenotypic and genotypic characterization of AmpCand ESBL-producing E. coli and K. pneumoniae
In total, 449 faecal samples were collected from corvids in five different sites across Canada. Of those, 21% (96/449) contained presumptive cefotaxime-resistant E. coli and 1% (3/449) contained cefotaxime-resistant K. pneumoniae (Table 1 ). The AmpC phenotype was expressed in 88 (92%; n = 96) E. coli isolates while the production of an ESBL enzyme was detected in eight E. coli (8%; n = 96). Of the three K. pneumoniae identified, one isolate expressed the AmpC phenotype and two produced ESBLs. Statistically significant difference in the prevalence of isolates with an AmpC phenotypes were seen between collection sites. AmpC phenotype presence was significantly higher in Nova Scotia than sites ON-1 (OR 2.2; CI 1.17, 4.45), ON-2 (OR 3.34; CI 1.65, 7.02), PEI (OR 12; CI 4.39, 41.2) and BC (OR 4.54; CI 1.70, 14.29).
Eighty-four (88%, n = 96) E. coli from the AmpC phenotype positive subset contained bla CMY-2 (n = 83) and bla (n = 1) genes (Table 1) . Four E. coli and one K. pneumoniae isolates were negative for all tested AmpC genes. Only E. coli carrying bla CMY-2 and bla CMY-42 were selected for further analysis. Genes bla TEM-1 and bla were identified in seven (8%, n = 84) and one (1%, n = 84) bla CMY-2 -producing E. coli, respectively (Table S2 , Supporting Information). The isolates were assigned to phylogenetic groups A (30/84 isolates, 36%), B1 (21/84, 25%), B2 (3/84, 4%) and D (30/84, 36%) (Table S2 , Supporting Information). All bla CMY -positive isolates were phenotypically resistant to ampicillin, amoxicillin-clavulanic acid and cephalothin with the following percentages of individual isolates resistant to the remaining panel: ceftazidime (96%), tetracycline (46%), streptomycin (44%), sulfonamide compounds (37%), chloramphenicol (15%), sulfamethoxazole-trimethoprim (15%), gentamicin (14%), nalidixic acid (2%) and ciprofloxacin (1%) ( Table S2 , Supporting Information). Extended-spectrum beta-lactamase-producing E. coli isolates contained bla CTX-M-1 (n = 3), bla CTX-M-32 (n = 2), bla CTX-M-14 (n = 2) and bla CTX-M-124 (n = 1) ( Table 1 ) and they were assigned to phylogenetic groups A (2/8 isolates, 25%) and D (6/8, 75%). Six isolates with bla CTX-M were multidrug-resistant (Fig. 1) . All ESBL-producing E. coli isolates were negative for genes coding for AmpC beta-lactamases. Two ESBL-producing K. pneumoniae carried beta-lactamase bla SHV-2 and fluoroquinolone resistance gene oqxAB (Fig. 2) .
Clonal similarity and MLST of the isolates
Overall, PFGE and MLST analTheysis demonstrated the high genetic diversity of the 92 AmpC-and ESBL-positive E. coli isolates from all sampling sites. Eighty-four bla CMY -positive strains displayed 70 unique macrorestriction profiles based on the criterion of 100% similarity of their PFGE patterns ( Figure S1 a-e, Supporting Information). Clonal similarity was demonstrated only among bla CMY isolates from Nova Scotia, where two main clusters were comprised of ST117 (4/27 isolates) and ST5881 isolates (n = 4) ( Figure S1e , Supporting Information). For further plasmid analysis of bla CMY -positive E. coli isolates in each sampling site, one isolate representing each PFGE cluster (70 in total) was selected (Fig. 1) . No significant clonal similarity was observed among E. coli isolates carrying ESBL genes (Fig. 1) , therefore all isolates were used for further plasmid typing.
Using MLST, all 92 AmpC-and ESBL-positive E. coli isolates were assigned to 42 different STs. The predominant sequence types (ST) included ST10 (8 isolates), ST58 (n = 8), ST38 (n = 7), ST117 (n = 7), ST5840 (n = 4) and ST5881 (n = 4) (Figs.  1 and 3 ). Ten bla CMY-2 -positive E. coli isolates were non-typeable using MLST, since PCR amplification of purA and mdhi genes (nine isolates) or gyrB and adk (one isolate) was not successful. ST38 was associated with both ESBL (bla CTX-M-32 and bla CTX-M-14 ) and AmpC (bla CMY-2 ) resistance mechanisms, as was ST117 with AmpC (bla CMY-2 ) and ESBL (bla CTX-M-1 ) (Figs. 1 and 3) . Nine novel E. coli STs carrying AmpC or ESBL were identified ( Figs. 1 and 2) . Four (n = 8, 50%) ESBL-producing E. coli isolates belonged to ST38, while both K. pneumoniae isolates were assigned to ST39.
One isolate with the AmpC bla CMY-2 gene from Nova Scotia was identified as the pandemic multidrug-resistant E. coli clone B2-O25b-ST131 but did not belong to the H30 or H30Rx subclone (Fig. 3) . Other clinically important clonal lineages were also found in our study. Seven ST117 isolates encoding bla CMY-2 (n = 6) and bla CTX-M-1 (n = 1) , respectively, were found in crows in Ontario (Waterloo and Woodstock) (Fig. 3) and Nova Scotia (Figs. 1 and 3), whereas two ST69 isolates with bla CMY-2 were identified in birds from Ontario and British Columbia.
Plasmids carrying bla CMY
Seventy representatives of bla CMY -positive isolates showing unique PFGE profiles were selected for further plasmid analysis. Fifty isolates (71%, n = 70) were mobilized (via transformation) and conjugative transfer of the gene to recipient cells of E. coli and Salmonella spp. was successful in 59 (84%, n = 70) and 63 (90%, n = 70) strains, respectively (Fig. 3) . Only bla CMY gene positive transformants (TFs) and transconjugants (TCs), harbouring a single plasmid, were used for further testing. Overall, 31 TFs and 34 E. coli TCs showing one plasmid were obtained from 70 representative isolates (Fig. 3) .
Sixty-five plasmids (one plasmid per representative isolate) carrying bla CMY gene had a variable size ranging from 45 to 190 kb (Fig. 1 ). They were assigned to diverse Inc types including IncI1 (45 plasmids), IncA/C (n = 10), IncK (n = 7) and IncI2 (n = 1). Two plasmids contained two replicons each (K-P and B/O-K) (Fig. 3) . The most prevalent IncI1 belonged to plasmid STs ST12 (29 plasmids), ST2 (n = 5), ST65 (n = 3), ST20 (n = 2), ST23 (n = 1), ST148 (n = 1), and novel ST233 (n = 1) and ST234 (n = 1). Two IncI1 could not be assigned to particular STs since PCR amplification of the sogS and pilL genes (one isolate) or ardA (one isolate) were not successful. None of the IncI1-containing isolates carried any additional resistance genes for which tests were performed, apart from bla CMY-2 . The majority of the IncI1-containing isolates (41/45 isolates), except those assigned to ST23, ST148 and ST234, contained the gene for production of colicin Ia/Ib (Fig. 3) . Twelve plasmids (18%, n = 65) carrying A/C, K or K-P replicons contained additional resistance to non-betalactam antimicrobials. All 10 IncA/C contained genes for resistance to sulfonamides, streptomycin, tetracycline and florfenicol (Fig. 3) .
Plasmids carrying bla CTX-M or bla SHV
The gene bla CTX-M was transferred by conjugation to recipient E. coli and Salmonella in three (38%, n = 8) and two (25%, n = 8) isolates, respectively. Using transformation, bla CTX-M was transmitted to recipient cells in three (38%, n = 8) isolates. Three plasmids carrying bla CTX-M-1 from three TFs were obtained for further testing (Fig. 1) , two of them belonged to IncI1/ST3 and one was identified as IncN/ST1 (Fig. 1) . As for the K. pneumoniae isolates, bla SHV-2 was transferred by conjugation to recipient strain of E. coli in one isolate but no recipient strain carrying one plasmid was found (Fig. 2) .
DISCUSSION
Crows and ravens commonly inhabit human-influenced environments that include urban residential and commercial areas, agricultural regions, landfills, hospitals and waste water treatment plants. The diets of crows and ravens in all of these environments allow for the mixing of bacterial populations originating from wild bird and human populations. Studies examining the transmission of AMR in natural environments have found evidence of AMR genes in the faecal bacteria of migrating bird populations Jamborova et al. 2015; Stedt et al. 2015; Alcalá et al. 2016) . The predominance of bla CMY-2 in the AmpC phenotype E. coli in our study is supported by other findings in North America. The bla CMY-2 has been described as the most prevalent plasmid-mediated AmpC beta-lactamase in human, animal and environmental samples in Canada and the USA (Pitout et al. 2007; Mataseje et al. 2009; Folster et al. 2010; Martin et al. 2012) and has recently been reported in corvid populations in the USA (Jamborova et al. 2017 ). In contrast to a similar study conducted in European rooks, the prevalence of AmpC-producing E. coli in Canadian corvids was notably higher (18.7%) than the European study, where it was calculated to be 4.4% (Jamborova et al. 2015) , suggesting a difference in population dynamics of antimicrobial resistance in E. coli between the two continents.
Our findings demonstrated a high diversity of both PFGE patterns and sequence types of E. coli containing bla CMY-2 overall, with no single dominant clone or sequence type present. This level of heterogeneity has also been found in AmpC-producing E. coli in hospital isolates in Canada (Denisuik et al. 2013) , suggesting the higher prevalence of bla CMY-2 in infection-causing E. coli in Canada is not caused by spread of a single resistant E. coli clone. Interestingly, a number of isolates from the corvids in this study were the same sequence types as those known to be of particular public health significance, namely ST69, ST117 and ST131 (Manges and Johnson 2012) . AmpC-producing E. coli ST131 is rarely documented in wildlife, but has been found in other wild bird populations (Alcala 2016; Jamborova 2017). Although we found only one isolate of the multidrug-resistant E. coli clone B2-O25b-ST131 containing the bla CMY-2 gene, the mobility of bacterial populations between different ecospheres is an important consideration when evaluating the spread of clones of public health significance. Likewise, the ST69 and ST117 are known clones associated with hospital-based and community-acquired infections (Simner et al. 2011; Manges and Johnson 2012) .
The role of plasmids in AMR epidemiology has been investigated in other bacterial populations within different animal and environmental host environments (Pitout et al. 2007; Mataseje et al. 2009; Folster et al. 2010; Martin et al. 2012; Bortolaia et al. 2014) . The IncI1 plasmids have been known to be conjugative and have previously been associated with possible transmission between E. coli strains isolated from human and animal sources in western Europe (Carattoli 2013; Day et al. 2016) . In this study, IncI1, specifically ST12 was the most prevalent plasmid in a diverse set of bla CMY-2 -positive E. coli isolates isolated from the different geographical locations. Likewise, IncI1/ST12 plasmid type plasmid associated with the bla CMY-2 gene has proliferated in Salmonella Heidelberg and other Enterobacteriaceae originating from humans and retail meat products in the USA (Folster et al. 2010) . The predominance of IncI1/ST12 as a Canadian bla CMY-2 carrying plasmid has furthermore been demonstrated in environmental and human E. coli and Salmonella (Mataseje et al. 2010) . The heterogeneity of the bacterial host population and the predominance of IncI1/ST12 suggests a horizontal gene transfer among bacterial populations with the potential to conjugate within the host animal (crow) gut system and be translocated to other ecospheres within the home range of crows.
The overall prevalence of 2.2% ESBL-producing isolates was lower than other reports from Europe in comparable bird species (rook, Corvus frugilegus), where an ESBL prevalence of 7.6% was observed (Jamborova et al. 2015) . The difference between these results indicates a different epidemiology of antimicrobial resistant bacteria in Europe and North America; one which has also been observed in farm animal environments Martin et al. 2012; Jones-Dias et al. 2016) . The CTX-M group of beta-lactamase enzymes present in E. coli of human isolates have been associated with human infection and have been found in food producing animals and other wildlife species (Naseer and Sundsfjord 2011, Alcala et al. 2016) . In comparison to this study, most prevalent CTX-M clusters in Europe have been reported to include CTX-M-1, CTX-M-3, CTX-M-32 and CTX-M-15 (Naseer, 2011) . Even with the low prevalence of ESBLs in our study, there was genetic diversity in the sequence types, gene variants and plasmid incompatibility groups within the isolates carrying those genes. Although rare, K. pneumoniae bla SHV-2 ESBLproducers were detected in our study and have been identified in Canadian hospital-based isolates (Melano et al. 2006; Denisuik et al. 2013; Karlowsky et al. 2013) . Further research into the prevalence and molecular characteristics of animal and environmental sourced isolates is needed to understand the epidemiology of ESBL-producing Klebsiella spp further.
Plasmid incompatability groups found in AmpC producers were also found among the ESLB isolates. Of the ESBL isolates, only bla CTX-M-1 was associated with IncI1/ST3 and N/ST1 plasmids. The broad-host-range plasmids such as IncN give these isolates an adaptability advantage to transmit this AMR gene with relative ease to bacterial hosts of the same or different species (Naseer and Sundsfjord 2011). Our findings showed E. coli isolates containing bla CTX-M-1 located on the IncI1/ST3 plasmid collected in Nova Scotia with distinct strain profiles. This profile has also been associated with avian derived isolates in the Netherlands, Italy, Poland and France as well as non-food producing animals and water in France [29] [30] [31] [32] [33] . Likewise, the highest prevalence of bla CMY-2 -positive isolates carrying replicon IncI1 was observed in the Nova Scotia sampling site, although this is also the site with the most samples. In the eastern most site of Canada (Nova Scotia), the presence of AmpC was significantly higher. The location in Nova Scotia was a semi-rural and predominantly agricultural area where poultry farming is prevalent. It is plausible that the crows had access and exposure to manure and carcasses from fields and manure piles. The sources of exposure for corvids will vary depending on the geographical location and the opportunistic dietary sources. The presence of poltry production units within the winter home range of the birds may be a possible exposure point as poultry production and poultry products are highly associated with bla CMY-2 and IncI1 plasmids (Martin et al. 2012) . Studies focusing on animal products found higher recovery of bla CMY-2 in poultry products than pork or beef in Canada, suggesting the bla CMY-2 presence in corvids may have originated from poultry sources (Aslam et al. 2012; Martin et al. 2012; Sheikh et al. 2012) . However, information of antimicrobial use in poultry production, poultry population density and disease pressures at the time of collection limit the conclusions that can be made in comparison to other sampling sites. Despite the remoteness of the British Columbian raven winter roost, ESBL and AmpC producers were found, highlighting the need for further study in more remote areas where easily accessible urban and agricultural food sources are limited. The proximity of crows to daily human activity and agriculture production has created a pathway of disseminating anthropogenically sourced bacteria with AMR genes on highly mobile plasmids into wild birds and into the greater natural environment. The occurrence of highly diverse E. coli and K. pneumoniae isolates containing ESBL and AmpC beta-lactamases, including clinically important clones and plasmid family types, have been documented here and are presently circulating in Canadian wildlife. With 21% of our collected bacterial isolates phenotypically resistant to cefotaxime, wildlife birds in Canada are potential vectors of resistance gene dissemination and indicators of antimicrobial resistance presence in the environment. This study highlights the contribution of corvids in Canada to the movement of AmpC/ESBL producing E. coli and K. pneumoniae between different ecospheres. advice and assistance and thank M. Phinney for sample collection in British Columbia. Thank you to the University of Veterinary and Pharmaceutical Sciences Brno, microbiology and molecular laboratory technicians J. Hofirkova, E. Suchanova and the research assistants of this project. We are grateful to the team of curators of the Institut Pasteur MLST and whole genome MLST and pMLST databases for curating the data and making them publicly available at http://bigsdb.web.pasteur.fr/. We thank to Lars Hansen (University of Copenhagen, Denmark), Lina Cavaco, Henrik Hasman (National Food Institute, Copenhagen, Denmark), James R. Johnson (University of Minnesota, Minneapolis, USA) and Alessandra Carattoli (Istituto Superiore di Sanità, Rome, Italy) for control strains and for advice on methodologies. We do not have any conflict of interest to report. Transparency declaration: None to declare.
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